UNSPSC 51173226: Dehydrocholic acid/docusate/phenolphthalein

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class GA209. This VA Drug Class (GA209) classifies this compound as belonging to the group LAXATIVES, OTHER.

UNSPSC 51173226 Dehydrocholic acid/docusate/phenolphthalein is a Commodity code that nominally identifies a specific laxative compound, but recent state and local procurement activity under this code does not reflect purchase of this pharmaceutical product. The three most recent opportunities posted under the code span drug testing services, pharmaceutical direct-to-manufacturer contracting strategy, and generic multi-source pharmaceutical supply — none of which involves the named compound. The mismatch between the code's nominal scope and the actual work being solicited suggests this code shows little relevant recent activity for vendors selling dehydrocholic acid/docusate/phenolphthalein formulations to state and local buyers.

Issuing bodies using this code include county criminal-justice departments, state health and human services commissions, and multi-state cooperative purchasing alliances. The Collin County Community Supervision and Corrections Department posted an RFP on July 9, 2026 (due July 23, 2026) for offender specimen collection and drug testing services, estimated at $600,000 annually, with lab screening and confirmation work that does not involve the named laxative. The Texas Health and Human Services Commission issued a Request for Information on April 3, 2026 seeking vendor capabilities for a Therapeutic Pharmacy Initiative Direct-to-Manufacturer Prescriptions program, focused on systemic pharmacy benefit contracting rather than specific pharmaceutical products. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) solicited generic multi-source pharmaceuticals and OTC products on January 20, 2026 (proposals due March 26, 2026) for distribution across participating state and local facilities in Minnesota and Oregon, with awards effective July 1, 2026. Recent activity centers on Texas and Minnesota, with no identifiable demand for the specific compound the code nominally represents.